Search research articles
Contact Us
Filters
Showing results (41-50 of 115) with videos related to
Page
of 12
Sort By:
British Journal of Cancer
|
April 7, 2011
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E Bignotti, M Ragnoli, L Zanotti, et al.
The Pharmacogenomics Journal
|
October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin
E Cecchin, G Perrone, S Nobili, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2013
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
F Loupakis, C Cremolini, L Salvatore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies
J Taieb, Q Shi, L Pederson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 24, 2025
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
R-D Hofheinz, E Fokas, L Benhaim, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 3, 2014
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity
B Spoto, E Di Betta, F Mattace-Raso, et al.
ESMO Open
|
October 1, 2025
Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial
Y Y Janjigian, A Kawazoe, J Xu, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 study
R Garcia-Carbonero, E Elez, P García-Alfonso, et al.
ESMO Open
|
October 2, 2024
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study
F Tosi, L Salvatore, E Tamburini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2013
FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO)
L Fornaro, S Lonardi, G Masi, et al.
Page
of 12
Search research articles
Search
Showing results (41-50 of 115) with videos related to
Sort By:
Page
of 12
British Journal of Cancer
|
April 7, 2011
Diagnostic and prognostic impact of serum HE4 detection in endometrial carcinoma patients
E Bignotti, M Ragnoli, L Zanotti, et al.
The Pharmacogenomics Journal
|
October 22, 2014
MTHFR-1298 A>C (rs1801131) is a predictor of survival in two cohorts of stage II/III colorectal cancer patients treated with adjuvant fluoropyrimidine chemotherapy with or without oxaliplatin
E Cecchin, G Perrone, S Nobili, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 22, 2013
FOLFOXIRI plus bevacizumab as first-line treatment in BRAF mutant metastatic colorectal cancer
F Loupakis, C Cremolini, L Salvatore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
July 4, 2019
Prognosis of microsatellite instability and/or mismatch repair deficiency stage III colon cancer patients after disease recurrence following adjuvant treatment: results of an ACCENT pooled analysis of seven studies
J Taieb, Q Shi, L Pederson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 24, 2025
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
R-D Hofheinz, E Fokas, L Benhaim, et al.
Nutrition, Metabolism, and Cardiovascular Diseases : NMCD
|
July 3, 2014
Pro- and anti-inflammatory cytokine gene expression in subcutaneous and visceral fat in severe obesity
B Spoto, E Di Betta, F Mattace-Raso, et al.
ESMO Open
|
October 1, 2025
Pembrolizumab with trastuzumab and chemotherapy for HER2-positive advanced gastric cancer: health-related quality-of-life analysis from the randomized KEYNOTE-811 trial
Y Y Janjigian, A Kawazoe, J Xu, et al.
ESMO Gastrointestinal Oncology
|
February 6, 2026
Analysis of fruquintinib in patients with metastatic colorectal cancer who were enrolled in Spain: results from the global FRESCO-2 study
R Garcia-Carbonero, E Elez, P García-Alfonso, et al.
ESMO Open
|
October 2, 2024
Curative immune checkpoint inhibitors therapy in patients with mismatch repair-deficient locally advanced rectal cancer: a real-world observational study
F Tosi, L Salvatore, E Tamburini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
May 14, 2013
FOLFOXIRI in combination with panitumumab as first-line treatment in quadruple wild-type (KRAS, NRAS, HRAS, BRAF) metastatic colorectal cancer patients: a phase II trial by the Gruppo Oncologico Nord Ovest (GONO)
L Fornaro, S Lonardi, G Masi, et al.
Page
of 12